ESCRS Homepage

March 2003
IN THIS ISSUE

New ESCRS trial in bid to cut endophthalmitis rate to 0.01%


Lasik corrects refractive errors after PK in selected patients

Africa-Luz mobilises to provide eye care in regions riven by poverty

Multifocal IOL
choice hinges on patterns of daily routine

Anti-histamine drug mitigates risk of developing DLK after Lasik, says study

Untreated eyelid inflammatory disorders pose risk for postoperative complications

Thermotopography shows ‘enormous promise’
for diagnosis and treatment of eye diseases

Lasik offers ‘very effective treatment’ for
refractive errors after PK, says US specialist

Good results with PRK and Lasek rival Lasik for top spot in refractive excimer laser surgery

Orbital lymphomas respond well to local, systemic therapies, says study

Laser technologies still beam but economy and consumer demand will determine future of refractive surgery

Legally blind cardiologist finds new beat in low vision rehabilitation

‘Pivotal’ anti-TGF antibody therapy reduces
filtering bleb wound formation, says report

Neuroprotective agents stem optic nerve damage
by ‘offering a solution’ to open-angle glaucoma

Echothiophate iodide shortage leaves US specialists struggling to find alternative for acute cases

Postoperative complications of PK will have serious consequences unless tackled 'aggressively’

Private refractive clinics claim young specialists as public waiting lists grow in Canadian eye surgery

German doctors’ helpers oil the cogs of the private ophthalmic practice

Study of 900 ICLs reveals good safety and long-term refractive results, says Spanish specialist

New toric IOL corrects high corneal astigmatism after cataract surgery, Austrian study reveals

IVF children run increased risk of developing
retinoblastoma, claim Dutch researchers

Suture-free DLEK preserves corneal surface topography and ensures faster wound healing

The day I said goodbye to cataracts and hello to the world without glasses

Retina specialists and trauma ophthalmologists
prepare to trade notes at joint Hungarian conference

Night blindness casts bogeyman into the shadows

Erbium laser phaco requires longer time but less energy for moderately hard cataracts

FEATURES
From The Editor
Reflections on Refractive Surgery
In Your Good Books
Bio-ophthalmology
In The Driving Seat
Prime Site
The Collector's Eye
Regulatory Matters



Night blindness casts bogeyman into the shadows

Dermot McGrath
in Glasgow, Scotland

THE bogeyman has traditionally taken the blame for children’s fear of the dark. But researchers in Scotland believe that a type of nyctalopia — or night blindness — could be the real culprit in some cases.

In an article published in the British Medical Journal, consultant ophthalmologist Gordon Dutton MD and his colleagues at Gartnavel General Hospital in Glasgow describe two children with an inherited form of stationary night blindness.
Both were very frightened of the dark, had a history of bumping into things at night and one child expressed a fear of shadows.

The first case was a three-year-old girl with no apparent visual problems who had always been scared of the dark. She complained to her parents of being able to see when the bedroom lights were off and refused to go to the bathroom, which was down a dark hallway, during the night. It was only when the girl’s younger sister was diagnosed with retinal problems that the parents had the older child’s eyes tested.

The second girl, aged two, also had a history of frequently tripping over and bumping into objects as well as problems seeing in the dark. Her parents reported that when she woke at night she would cry but would not go to her parents’ bedroom. She also needed to have curtains drawn at night because of her fear of the darkness beyond the windows.

In both cases, electrophysiology tests revealed a “negative” electroretinogram consistent with a diagnosis of congenital stationary night blindness.
Congenital stationary night blindness — so called because it doesn’t change throughout life — is rare and its prevalence has not been well established, although it is about three times more common in boys than in girls, according to the researchers.

The condition is an inherited, non-progressive disorder principally affecting rod photoreceptor function in the retina, resulting in impaired night vision, although there is commonly a mild impairment in cone function, which may affect daytime central visual acuity.
The defective pathway appears to result from a signal transmission defect from the photoreceptors.

It principally manifests itself as an increase of the dark adaptation threshold, nystagmus, and often moderate to high short-sightedness, although the refractive state may be far-sighted or normal. Squint, pale or tilted optic discs, and paradoxical pupil responses have all been linked to the condition.

There is usually no visual deficit in good lighting conditions but mild central visual loss is common in some inherited forms. Fundus examination is usually normal, distinguishing it from the progressive conditions causing nyctalopia.

The researchers said children’s fear of the dark is often dismissed as little more than attention-seeking behaviour or irrational fear that will fade over time.
They recommend that in cases where children are afraid of the dark, doctors need to take a full family history to find out about visual problems. This should then be followed by a complete ocular examination and electroretinography to determine whether the children are suffering from night blindness.

“Night blindness in children can bring about profound fear of the dark. Recognition of the diagnosis and the simple expedient of giving the child control of lighting conditions can transform family life,” the researchers’ report concluded.

Top